from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3047c/-

LFCtreatmentdescriptionclass of inhibitor

1.994

Amikacinug/mL Amikacintranslation

3.558

Cap5-10ug/mL Capreomycintranslation

1.520

Rox10-50 ug/mL Roxithromycintranslation

0.802

SM2-5 ug/mL Streptomycintranslation

1.543

Tet5-10 ug/mL Tetracyclinetranslation

0.035

Rif0.2-5ug/mL Rifampicintranscription

-0.131

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.630

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.448

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.632

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.966

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.030

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.630

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.538

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.440

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.857

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.225

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.318

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.081

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.239

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.635

KCN5-20 ug/mL Potassium cyaniderespiration

0.850

NaN30.2-2 mM Sodium aziderespiration

0.018

Nigericin50 uM Nigericinrespiration

-0.177

TRC10-150 ug/mL Triclosanrespiration

-0.149

TRZ10-25 ug/mL Thioridazinerespiration

2.016

Valinomycin0.5-10 uM Valinomycinrespiration

0.575

ZnSO42 mM ZnSO4respiration

-0.090

menadione6-10 ug/mL Menadionerespiration

0.616

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.106

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.153

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.133

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.936

NRP_1Non-replicating persistence stage 1dosRassociated

-0.325

Amp0.2mg/mL AmpicillincellWall

-0.079

Cephalexin20-100 ug/mL CephalexincellWall

0.571

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.097

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.419

EMB10-20 ug/mL EthambutolcellWall

0.047

Eta12-40 ug/mL EthionamidecellWall

0.622

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.634

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.381

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.602

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.459

BZA0.12 mg/mL BenzamidearomaticAmides

-0.060

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.140

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.161

H2O24 mM hydrogen peroxideDNAdamaging

0.679

Levo10 ug/mL LevofloxacinDNAdamaging

-0.627

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.612

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.813

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.339

UVUV-irradiationDNAdamaging

0.391

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.148

Antimycin12.5-50 ug/mL Antimycin A?

0.417

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.027

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.381

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.459

PA8240.2-2 ug/mL PA-824?

0.992

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.195

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.046

Verapamil50 uM Verapamil?

0.202

mercaptoethanol2 mM 2-Mercaptoethanol?

0.176

methoxatin10-20 ug/mL Methoxatin?